Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-20-031015

President & CEO sold 8,968 shares at $22.51 ($201,870)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBIN HOWARD W President & CEO 2020-05-18 Sale −8,968 $22.51 $201,870 375,903 D: show line 1 in the form
Open-market sales · 8,968 sh · avg $22.51 · $201,870
Loading xslF345X03/doc4.xml…